Omega-3: from academia to commercial blockbuster

By Shane Starling

- Last updated on GMT

Related tags Nutrition Fatty acid Eicosapentaenoic acid

Omega-3: from academia to commercial blockbuster
Omega-3 veteran Ian Newton shares three decades-worth of industry experience that has seen the fatty acid go from non-existent to heavy blip on the nutritional radar.

Newton tells Shane Starling how omega-3s have advanced out of academic and pharmaceuticals worlds and into nutraceutical and functional foods applications that form a multi-billion dollar, supplements-dominated market today.

He tracks the expansion of omega-3 science from an initial body of heart-based research to “the next wave” ​of research citing omega-3 benefits for bones, pregnant women, embryos and infants, as well as brain and visual health.

Omega-3 developments in crops may offer new sources in the future with 15 percent EPA (eicosapentaenoic acid) and oil content already possible from, “canola and flax-type crops”.

Newton sees biofuels is offering a lot of potential that could, “relieve the pressure on the sustainability of the whole fish area”.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 18-Jun-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Ride the next wave of omega-3 innovation

Ride the next wave of omega-3 innovation

Content provided by dsm-firmenich | 01-Jun-2024 | Insight Guide

Fish oil supplies can’t scale to meet the needs of the planet’s growing population, but life’s®OMEGA can.

Related suppliers

Follow us

Products

View more

Webinars